CVS brings back coverage for Lilly's obesity drug Zepbound - Reuters

CVS brings back coverage for Lilly's obesity drug Zepbound    Reuters CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans    CNBC Foundayo and Zepbound now covered for millions of Americans    investor.lilly.com CVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlash    NBC News Pharmalittle: We're reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more    statnews.com

Original source: Google News IR